Go Deep
Anuh Pharma Limited
Anuh Pharma Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 24,053 | 25.0 | 2.55 | 0.00 | 89.46 |
| Sep 2026 | 24,053 | 25.3 | 2.55 | 0.00 | 89.46 |
| Sep 2026 | 24,053 | 25.3 | 2.55 | 0.00 | 89.46 |
| Oct 2026 | 24,167 | 24.0 | 2.44 | 0.00 | 85.85 |
| Oct 2026 | 23,565 | 18.6 | 2.33 | 0.00 | 82.02 |
Anuh Pharma Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,938,104,000.0 | 2,021,172,000.0 | 1,971,781,000.0 | 1,858,827,000.0 |
| Net Profit | 114,249,000.0 | 116,814,000.0 | 134,510,000.0 | 76,125,000.0 |
| EPS | 1.1 | 1.2 | 1.3 | 0.8 |
Anuh Pharma Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 7,716,574,000.0 | 6,615,149,000.0 | 6,470,043,000.0 | 5,274,860,000.0 |
| Net Profit | 410,461,000.0 | 473,519,000.0 | 600,575,000.0 | 361,796,000.0 |
| EPS | 4.1 | 2.4 | 6.0 | 3.6 |
Anuh Pharma Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 5,573,679,000.0 | 5,066,277,000.0 | 4,456,800,000.0 | 4,049,801,000.0 | — |
| Total Liabilities | 2,051,455,000.0 | 1,806,030,000.0 | 1,544,621,000.0 | 1,637,589,000.0 | — |
| Total Equity | 3,522,224,000.0 | 3,260,247,000.0 | 2,912,179,000.0 | 2,412,212,000.0 | — |
Owes vs Owns
Anuh Pharma Limited owed ₹0.37 for every ₹1 it owned in Mar 2026, down from ₹0.40 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.37× | 0.36× | 0.35× | 0.40× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Anuh Pharma Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 9.5%Receivables 42.8%Inventory 26.5%Fixed assets (tangible) 10.1%Long-term investments 7.1%Other assets 3.9%
How it's funded — Mar 2026
Payables 33.7%Other liabilities 3.1%Shareholders' equity 63.2%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 52.9 | 73.4 | 62.3 | 53.1 |
| Receivables | 238.6 | 215.9 | 189.9 | 171.2 |
| Inventory | 147.8 | 74.5 | 75.4 | 72.6 |
| Fixed assets (tangible) | 56.1 | 60.4 | 49.2 | 53.3 |
| Intangible assets | 0.5 | 0.1 | 0.2 | 0.1 |
| Long-term investments | 39.6 | 62.0 | 51.7 | 39.7 |
| Other assets | 21.8 | 20.4 | 17.0 | 15.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 10.5 | 2.0 | 0.0 |
| Long-term debt | 0.0 | 0.1 | 0.4 | 0.8 |
| Payables | 187.7 | 156.8 | 140.5 | 152.8 |
| Other liabilities | 17.5 | 13.2 | 11.6 | 10.2 |
| Shareholders' equity | 352.2 | 326.0 | 291.2 | 241.2 |
| Net tangible assets | 351.7 | 325.9 | 291.1 | 241.1 |
Anuh Pharma Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -30,116,000.0 | 371,247,000.0 | 129,251,000.0 | 539,016,000.0 | — |
| Investing Activities | 178,415,000.0 | -199,094,000.0 | 9,182,000.0 | -434,837,000.0 | — |
| Financing Activities | -263,275,000.0 | -48,597,000.0 | -85,684,000.0 | -122,869,000.0 | — |